Global Companion Diagnostics Market Size study & Forecast, by Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing and Other Technologies) by Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma and Other Indications), By End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs and Others)and Regional Analysis, 2022-2029
Global Companion Diagnostics Market is valued at approximately USD 6.80 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 11.0% over the forecast period 2022-2029. A companion diagnostic is a test used to ensure the usage of a comparable biological product or medication is both safe and effective. These tests are typically used to diagnose cancer. In this, an appropriate medicine is recommended based on the identified biomarker. Based on a particular patient's response, these tests offer personalized treatment. The Companion Diagnostics market is expanding because of factors such as the increasing incidence of Cancer and rising Regulatory Approvals of New Tests for Different Indications.
The rising prevalence of cancer globally is fostering market growth, according to statistics published by the World Health Organization (WHO) in February 2022, approximately 400,000 children develop cancer worldwide every year. Also, according to the statistics published by the World Cancer Research Fund International, in 2020, there were 18,094,716 million cases of cancer diagnosed globally. The International Agency for Research on Cancer estimated increase in the worldwide burden of cancer is to 27.5 million new cases by 2040. The usage of these tests is increasing due to the increased incidence of cancer worldwide, which is boosting the market's expansion. Also, it is anticipated that regulatory approvals of these tests for various indications will expand the market. For instance, in August 2022, the U.S. FDA approved Thermo Fisher Scientific Inc.'s Oncomine Dx Target Test as a companion diagnostic (CDx). This test identifies non-small cell lung cancer tumours that exhibit HER2 (ERBB2) activating mutations (SNVs & Exon 20 Insertion). In addition, the co-development of drug and diagnostic technology and favorable government support is creating lucrative growth in the market. However, the high cost of drug development and associated clinical trials may halt market growth.
The key regions considered for the Global Companion Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising drug discovery activities, rising prevalence of diseases and rising regulatory approvals in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising disease prevalence, an increase in the number of collaborations for drug development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Abbott Laboratories
Agilent Technologies Inc.
F.Hoffmann-La Roche Ltd
Biomerieux SA
Qiagen NV
Siemens Healthcare Gmbh
Thermo Fisher Scientific Inc.
Danaher Corporation (Beckman Coulter Inc.)
Almac Group
Illumina Inc.
Recent Developments in the Market:
In January 2022, Amoy Diagnostics Co. Ltd., and PREMIA Holdings (HK) Limited introduced the AmoyDx Pan Lung Cancer PCR Panel (the 'PLC Panel') in Japan as a reimbursed companion diagnostic for various anti-cancer drugs.
In January 2021,In partnership with OmniSeq Corporation, Laboratory Corporation of America Holdings unveiled OmniSeq INSIGHTsm, a complete tissue-based test for genomic and immunological profiling that makes use of next-generation sequencing (NGS) technology. By advancing precision oncology, the test hopes to enhance patient outcomes..
Global Companion Diagnostics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Indication, End User Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Immunohistochemistry (IHC)
Polymerase Chain Reaction (PCR)
In-situ Hybridization (ISH)
Real-time PCR (RT-PCR)
Gene Sequencing
Other Technologies
By Indication:
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Melanoma
Other Indications
By End User:
Pharmaceutical & Biopharmaceutical Companies
Reference Laboratories
CROs
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
The rising prevalence of cancer globally is fostering market growth, according to statistics published by the World Health Organization (WHO) in February 2022, approximately 400,000 children develop cancer worldwide every year. Also, according to the statistics published by the World Cancer Research Fund International, in 2020, there were 18,094,716 million cases of cancer diagnosed globally. The International Agency for Research on Cancer estimated increase in the worldwide burden of cancer is to 27.5 million new cases by 2040. The usage of these tests is increasing due to the increased incidence of cancer worldwide, which is boosting the market's expansion. Also, it is anticipated that regulatory approvals of these tests for various indications will expand the market. For instance, in August 2022, the U.S. FDA approved Thermo Fisher Scientific Inc.'s Oncomine Dx Target Test as a companion diagnostic (CDx). This test identifies non-small cell lung cancer tumours that exhibit HER2 (ERBB2) activating mutations (SNVs & Exon 20 Insertion). In addition, the co-development of drug and diagnostic technology and favorable government support is creating lucrative growth in the market. However, the high cost of drug development and associated clinical trials may halt market growth.
The key regions considered for the Global Companion Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising drug discovery activities, rising prevalence of diseases and rising regulatory approvals in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising disease prevalence, an increase in the number of collaborations for drug development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Abbott Laboratories
Agilent Technologies Inc.
F.Hoffmann-La Roche Ltd
Biomerieux SA
Qiagen NV
Siemens Healthcare Gmbh
Thermo Fisher Scientific Inc.
Danaher Corporation (Beckman Coulter Inc.)
Almac Group
Illumina Inc.
Recent Developments in the Market:
In January 2022, Amoy Diagnostics Co. Ltd., and PREMIA Holdings (HK) Limited introduced the AmoyDx Pan Lung Cancer PCR Panel (the 'PLC Panel') in Japan as a reimbursed companion diagnostic for various anti-cancer drugs.
In January 2021,In partnership with OmniSeq Corporation, Laboratory Corporation of America Holdings unveiled OmniSeq INSIGHTsm, a complete tissue-based test for genomic and immunological profiling that makes use of next-generation sequencing (NGS) technology. By advancing precision oncology, the test hopes to enhance patient outcomes..
Global Companion Diagnostics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Indication, End User Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Immunohistochemistry (IHC)
Polymerase Chain Reaction (PCR)
In-situ Hybridization (ISH)
Real-time PCR (RT-PCR)
Gene Sequencing
Other Technologies
By Indication:
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Melanoma
Other Indications
By End User:
Pharmaceutical & Biopharmaceutical Companies
Reference Laboratories
CROs
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Companion Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Companion Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.2.3. Companion Diagnostics Market, by Indication, 2019-2029 (USD Billion)
1.2.4. Companion Diagnostics Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL COMPANION DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL COMPANION DIAGNOSTICS MARKET DYNAMICS
3.1. Companion Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of Cancer
3.1.1.2. Rising Regulatory Approvals of New Tests for Different Indications
3.1.2. Market Challenges
3.1.2.1. High Cost of Drug Development and Associated Clinical Trials
3.1.3. Market Opportunities
3.1.3.1. Co-development of Drug and Diagnostic Technology
3.1.3.2. Favourable government support
CHAPTER 4. GLOBAL COMPANION DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Global Companion Diagnostics Market by Technology, Performance - Potential Analysis
6.3. Global Companion Diagnostics Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
6.4. Companion Diagnostics Market, Sub Segment Analysis
6.4.1. Immunohistochemistry (IHC)
6.4.2. Polymerase Chain Reaction (PCR)
6.4.3. In-situ Hybridization (ISH)
6.4.4. Real-time PCR (RT-PCR)
6.4.5. Gene Sequencing
6.4.6. Other Technologies
CHAPTER 7. GLOBAL COMPANION DIAGNOSTICS MARKET, BY INDICATION
7.1. Market Snapshot
7.2. Global Companion Diagnostics Market by Indication, Performance - Potential Analysis
7.3. Global Companion Diagnostics Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
7.4. Companion Diagnostics Market, Sub Segment Analysis
7.4.1. Lung Cancer
7.4.2. Breast Cancer
7.4.3. Colorectal Cancer
7.4.4. Leukemia
7.4.5. Melanoma
7.4.6. Other Indications
CHAPTER 8. GLOBAL COMPANION DIAGNOSTICS MARKET, BY END USER
8.1. Market Snapshot
8.2. Global Companion Diagnostics Market by End User, Performance - Potential Analysis
8.3. Global Companion Diagnostics Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
8.4. Companion Diagnostics Market, Sub Segment Analysis
8.4.1. Pharmaceutical & Biopharmaceutical Companies
8.4.2. Reference Laboratories
8.4.3. CROs
8.4.4. Others
CHAPTER 9. GLOBAL COMPANION DIAGNOSTICS MARKET, REGIONAL ANALYSIS
9.1. Companion Diagnostics Market, Regional Market Snapshot
9.2. North America Companion Diagnostics Market
9.2.1. U.S. Companion Diagnostics Market
9.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Companion Diagnostics Market
9.3. Europe Companion Diagnostics Market Snapshot
9.3.1. U.K. Companion Diagnostics Market
9.3.2. Germany Companion Diagnostics Market
9.3.3. France Companion Diagnostics Market
9.3.4. Spain Companion Diagnostics Market
9.3.5. Italy Companion Diagnostics Market
9.3.6. Rest of Europe Companion Diagnostics Market
9.4. Asia-Pacific Companion Diagnostics Market Snapshot
9.4.1. China Companion Diagnostics Market
9.4.2. India Companion Diagnostics Market
9.4.3. Japan Companion Diagnostics Market
9.4.4. Australia Companion Diagnostics Market
9.4.5. South Korea Companion Diagnostics Market
9.4.6. Rest of Asia Pacific Companion Diagnostics Market
9.5. Latin America Companion Diagnostics Market Snapshot
9.5.1. Brazil Companion Diagnostics Market
9.5.2. Mexico Companion Diagnostics Market
9.5.3. Rest of Latin America Companion Diagnostics Market
9.6. Rest of The World Companion Diagnostics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Agilent Technologies Inc.
10.2.3. F.Hoffmann-La Roche Ltd
10.2.4. Biomerieux SA
10.2.5. Qiagen NV
10.2.6. Siemens Healthcare Gmbh
10.2.7. Thermo Fisher Scientific Inc.
10.2.8. Danaher Corporation (Beckman Coulter Inc.)
10.2.9. Almac Group
10.2.10. Illumina Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Companion Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Companion Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.2.3. Companion Diagnostics Market, by Indication, 2019-2029 (USD Billion)
1.2.4. Companion Diagnostics Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL COMPANION DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL COMPANION DIAGNOSTICS MARKET DYNAMICS
3.1. Companion Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of Cancer
3.1.1.2. Rising Regulatory Approvals of New Tests for Different Indications
3.1.2. Market Challenges
3.1.2.1. High Cost of Drug Development and Associated Clinical Trials
3.1.3. Market Opportunities
3.1.3.1. Co-development of Drug and Diagnostic Technology
3.1.3.2. Favourable government support
CHAPTER 4. GLOBAL COMPANION DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Global Companion Diagnostics Market by Technology, Performance - Potential Analysis
6.3. Global Companion Diagnostics Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
6.4. Companion Diagnostics Market, Sub Segment Analysis
6.4.1. Immunohistochemistry (IHC)
6.4.2. Polymerase Chain Reaction (PCR)
6.4.3. In-situ Hybridization (ISH)
6.4.4. Real-time PCR (RT-PCR)
6.4.5. Gene Sequencing
6.4.6. Other Technologies
CHAPTER 7. GLOBAL COMPANION DIAGNOSTICS MARKET, BY INDICATION
7.1. Market Snapshot
7.2. Global Companion Diagnostics Market by Indication, Performance - Potential Analysis
7.3. Global Companion Diagnostics Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
7.4. Companion Diagnostics Market, Sub Segment Analysis
7.4.1. Lung Cancer
7.4.2. Breast Cancer
7.4.3. Colorectal Cancer
7.4.4. Leukemia
7.4.5. Melanoma
7.4.6. Other Indications
CHAPTER 8. GLOBAL COMPANION DIAGNOSTICS MARKET, BY END USER
8.1. Market Snapshot
8.2. Global Companion Diagnostics Market by End User, Performance - Potential Analysis
8.3. Global Companion Diagnostics Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
8.4. Companion Diagnostics Market, Sub Segment Analysis
8.4.1. Pharmaceutical & Biopharmaceutical Companies
8.4.2. Reference Laboratories
8.4.3. CROs
8.4.4. Others
CHAPTER 9. GLOBAL COMPANION DIAGNOSTICS MARKET, REGIONAL ANALYSIS
9.1. Companion Diagnostics Market, Regional Market Snapshot
9.2. North America Companion Diagnostics Market
9.2.1. U.S. Companion Diagnostics Market
9.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Companion Diagnostics Market
9.3. Europe Companion Diagnostics Market Snapshot
9.3.1. U.K. Companion Diagnostics Market
9.3.2. Germany Companion Diagnostics Market
9.3.3. France Companion Diagnostics Market
9.3.4. Spain Companion Diagnostics Market
9.3.5. Italy Companion Diagnostics Market
9.3.6. Rest of Europe Companion Diagnostics Market
9.4. Asia-Pacific Companion Diagnostics Market Snapshot
9.4.1. China Companion Diagnostics Market
9.4.2. India Companion Diagnostics Market
9.4.3. Japan Companion Diagnostics Market
9.4.4. Australia Companion Diagnostics Market
9.4.5. South Korea Companion Diagnostics Market
9.4.6. Rest of Asia Pacific Companion Diagnostics Market
9.5. Latin America Companion Diagnostics Market Snapshot
9.5.1. Brazil Companion Diagnostics Market
9.5.2. Mexico Companion Diagnostics Market
9.5.3. Rest of Latin America Companion Diagnostics Market
9.6. Rest of The World Companion Diagnostics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Agilent Technologies Inc.
10.2.3. F.Hoffmann-La Roche Ltd
10.2.4. Biomerieux SA
10.2.5. Qiagen NV
10.2.6. Siemens Healthcare Gmbh
10.2.7. Thermo Fisher Scientific Inc.
10.2.8. Danaher Corporation (Beckman Coulter Inc.)
10.2.9. Almac Group
10.2.10. Illumina Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Companion Diagnostics Market, report scope
TABLE 2. Global Companion Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Companion Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 4. Global Companion Diagnostics Market estimates & forecasts by Indication 2019-2029 (USD Billion)
TABLE 5. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Companion Diagnostics Market
TABLE 70. List of primary sources, used in the study of global Companion Diagnostics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Companion Diagnostics Market, report scope
TABLE 2. Global Companion Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Companion Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 4. Global Companion Diagnostics Market estimates & forecasts by Indication 2019-2029 (USD Billion)
TABLE 5. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Companion Diagnostics Market
TABLE 70. List of primary sources, used in the study of global Companion Diagnostics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Companion Diagnostics Market, research methodology
FIG 2. Global Companion Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Companion Diagnostics Market, key trends 2021
FIG 5. Global Companion Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Companion Diagnostics Market, porters 5 force model
FIG 7. Global Companion Diagnostics Market, pest analysis
FIG 8. Global Companion Diagnostics Market, value chain analysis
FIG 9. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Companion Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Companion Diagnostics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Companion Diagnostics Market, research methodology
FIG 2. Global Companion Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Companion Diagnostics Market, key trends 2021
FIG 5. Global Companion Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Companion Diagnostics Market, porters 5 force model
FIG 7. Global Companion Diagnostics Market, pest analysis
FIG 8. Global Companion Diagnostics Market, value chain analysis
FIG 9. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Companion Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Companion Diagnostics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
